Prostate cancer is one of the most common cancers in men and usually occurs at an older age. Although this cancer arising in the prostate gland is often slow-growing, it can show more aggressive features in some patients. For this reason, early diagnosis and correct treatment planning are very important.
There may be no symptoms in the early stages of the disease. In later stages, complaints such as difficulty urinating, frequent urination, a weak urine stream or blood in the urine can occur. Regular check-ups allow prostate cancer to be detected at an early stage.
The PSA (Prostate Specific Antigen) test, clinical examination and prostate biopsy are the primary methods for diagnosing prostate cancer. When necessary, magnetic resonance imaging and other advanced tests assess the tumor's extent within the prostate and its relationship to surrounding tissue in detail.
Based on the findings, the disease's stage and risk group are determined, and a treatment plan is built specifically for the patient.
Treatment of prostate cancers is planned according to the disease's stage, biological characteristics, and the patient's age and general health. Active surveillance may be considered for early-stage patients, while surgery or other treatment approaches may also be considered.
The main goal of the treatment process is to control the cancer, prevent progression of the disease and preserve the patient's quality of life. The treatment decision is made in light of individual evaluation and scientific data.
Patients are placed on a regular follow-up program after treatment. The course of the disease is monitored through PSA checks, clinical evaluations and necessary imaging tests.
This follow-up process is very important for detecting the risk of recurrence early and achieving healthy long-term results.
